Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lung Adenocarcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00103142
What this trial is testing

Vaccine Therapy in Treating Patients With Liver or Lung Metastases From Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
Michael Morse, MD 74
Early research (Phase 1)Ended earlyNCT05462873
What this trial is testing

Investigate the Safety and Tolerability of Intravenous QEQ278 in Patients With Advanced Solid Tumors

Who this might be right for
Carcinoma, Non-Small-Cell LungCarcinoma, Renal CellEsophageal Squamous Cell Carcinoma+1 more
Novartis Pharmaceuticals 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT05651022
What this trial is testing

Study of DECOY20 With or Without Tislelizumab in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor, AdultHCC - Hepatocellular CarcinomaCRC (Colorectal Cancer)+5 more
Indaptus Therapeutics, Inc 120
Testing effectiveness (Phase 2)Looking for participantsNCT05363280
What this trial is testing

Phase 2 Study for the Patient, Who Has Diagnosed With Small Cell Lung Cancer (SCLC) or Non Small Cell Lung Cancer (NSCLC) or Renal Cell Carcinoma (RCC) and Finished the First Line Stand Treatment , Need More Treatment

Who this might be right for
Small Cell Lung CancerRenal Cell Carcinoma (RCC)Non-Small Cell Lung
Advenchen Pharmaceuticals, LLC. 80
Testing effectiveness (Phase 2)Study completedNCT01156545
What this trial is testing

BIBW 2992 Plus Simvastatin vs. BIBW 2992 in Previously Treated Patients With Advanced Non-adenocarcinomatous NSCLC

Who this might be right for
Non-small Cell Lung Cancer
National Cancer Center, Korea 68
Testing effectiveness (Phase 2)Study completedNCT00042679
What this trial is testing

Trial of Antisense Nucleotide to PKC-Alpha (LY900003, ISIS 3521) Plus Gemcitabine and Carboplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer.

Who this might be right for
Carcinoma, Non-Small-Cell LungPulmonary NeoplasmsNeoplasms, Lung
Eli Lilly and Company
Early research (Phase 1)Study completedNCT00005842
What this trial is testing

Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Cancer
National Cancer Institute (NCI) 24
Early research (Phase 1)Temporarily pausedNCT07181720
What this trial is testing

CD70-Targeted CAR-T Therapy in CD70-Positive Advanced Solid Tumors

Who this might be right for
Renal Cell Carcinoma (RCC)Lung CancerAnaplastic Thyroid Carcinomas+3 more
Chongqing Precision Biotech Co., Ltd 90
Testing effectiveness (Phase 2)UnknownNCT04459078
What this trial is testing

Clinical Study of Camrelizumab Combined With APatinib and Albumin Paclitacxel in Patients With Advanced Lung Adenocarcinoma

Who this might be right for
Adenocarcinoma of the Lung
Hunan Cancer Hospital 63
Large-scale testing (Phase 3)Study completedNCT00966914
What this trial is testing

Phase 3 Study of Tavocept Versus Placebo in Patients With Newly Diagnosed or Relapsed Advanced Primary Adenocarcinoma of the Lung Treated With Docetaxel or Paclitaxel Plus Cisplatin

Who this might be right for
Non-small Cell Lung Cancer
BioNumerik Pharmaceuticals, Inc. 540
Not applicableUnknownNCT06215885
What this trial is testing

Multi-omics Analysis to Characterize the Invasive Evolution of Pulmonary Subsolid Nodules

Who this might be right for
Adenocarcinoma of Lung
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 220
Not applicableStudy completedNCT04202614
What this trial is testing

Prognostic Role of Positron Emission Tomography and Computed Tomography Parameters in Stage I Lung Adenocarcinoma

Who this might be right for
Stage I Pulmonary Adenocarcinoma
IRCCS San Raffaele 58
Testing effectiveness (Phase 2)Ended earlyNCT04785287
What this trial is testing

Anti-CTLA4-NF mAb (BMS986218), Nivolumab, and Stereotactic Body Radiation Therapy for the Treatment of Metastatic Solid Malignancies

Who this might be right for
Advanced Lung CarcinomaAdvanced Malignant Solid NeoplasmMalignant Adrenal Gland Neoplasm+14 more
M.D. Anderson Cancer Center 13
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07576725
What this trial is testing

Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+40 more
Fred Hutchinson Cancer Center 50
Not applicableLooking for participantsNCT07171190
What this trial is testing

Targeted Abdominal CT in Conjunction With Lung Cancer Screening

Who this might be right for
Renal Cell Carcinoma (Kidney Cancer)Kidney CancersAAA - Abdominal Aortic Aneurysm+1 more
University of Cambridge 6,272
Not applicableUnknownNCT04708483
What this trial is testing

DCE-CT of Thoracic Tumors as an Early Biomarker for Treatment Monitoring in Comparison With Morphologic Criteria

Who this might be right for
Cancer, LungPerfusion Computed Tomography Target LesionCancer Liver+2 more
Hyperfusion 100
Early research (Phase 1)Looking for participantsNCT06687941
What this trial is testing

Evaluate the Tolerability, Safety, and PK of AST-201 in Patients With GPC3-positive Advanced Solid Tumors

Who this might be right for
NeoplasmsCarcinoma, HepatocellularCarcinoma, Non-Small-Cell Lung+1 more
Aptamer Sciences, Inc. 70
Post-approval studies (Phase 4)UnknownNCT02804646
What this trial is testing

Endostar Durative Transfusion Combined With Chemotherapy in the Treatment of Advanced Lung Adenocarcinoma

Who this might be right for
Adenocarcinoma of Lung
Anhui Provincial Hospital 100
Not applicableNot Yet RecruitingNCT07630246
What this trial is testing

CLINICAL STUDY TO IDENTIFY BIOMARKERS FOR TUMOR SPREAD THROUGH AIR SPACES STATUS

Who this might be right for
Lung Adenocarcinoma
Universidade Nova de Lisboa 140
Early research (Phase 1)Looking for participantsNCT06040541
What this trial is testing

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)Colorectal Cancer (CRC)Pancreatic Ductal Adenocarcinoma (PDAC)+1 more
Revolution Medicines, Inc. 604
Next Page